Success metrics in an accountable care organization (ACO) can be extensive in scope, from quality to cost to utilization to patient satisfaction—and all of these factors are important.
Going Global: Should You Take the Leap?
Before moving into the global market, a company needs to understand the local structure of geographic regions.
Emerging Markets Grow, U.S. to Fall Short in Global Non-Vascular Stent Market
The device tax, regulatory scrutiny, and a failure to address unmet clinical needs are among the reasons that the United States will fall behind other major markets.
J&J Sags in Medical Device, Still Plans to Launch 30 Products by 2016
Johnson & Johnson holds firm that it will continue to accelerate in the innovation department over the next year.
Medtronic and IBM Partner to Transform Diabetes Management
IBM’s Watson Health Unit is forming several collaborations to facilitate personalized health on a massive scale.
What Manufacturers Should Know About Reimbursement and Case Management Hotlines for Providers
While support services are important, manufacturers must be aware of both state and Federal regulations, as there can be conflicts and differences in interpretations.
Next-Generation Transcatheter Aortic Valve Replacements Will Drive Rapid Market Growth
The market value for transcatheter heart valves will exceed $3 billion by 2020, and adoption of next-generation valves will drive significant market growth, provided that positive clinical data continues, according to research and consulting firm GlobalData.
Medical Device Joint Ventures and Acquisitions in Asia
Acquisitions and joint ventures with Asian medical companies can provide many advantages for Western firms looking to grow their businesses in Asian medical device markets.
Living with a Legacy – Reimbursement Barriers Based on Technologies that Came Before
Prior “aggressive” tactics of manufacturers launching new technology can poison the reimbursement environment for a related, but distinct technology occupying the same space. This discussion traces the history of two of the most challenging reimbursement environments: wound healing and spine technologies.
Johnson & Johnson to Sell Cordis to Cardinal Health for $1.94 billion.
Cardinal CEO George Barrett has said that the company may make more acquisitions in cardiology and endovascular treatment as well as in the trauma and wound care segment.
